Retrexa Hybrid multi-dose pen and packaging on a reflective surface with a starry night sky background
Noventra Pharma Retrexa Hybrid multi-dose pen set on a dark background
Retrexa Hybrid multi-dose pen kit
Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Noventra Retrexa Hybrid R3t@trutide & Naltrexone Pen 44mg

R 2,390.00 R 2,220.00
Add to WishlistCompare

Retrexa Hybrid is an advanced metabolic peptide blend combining R3t@trutide 32mg and Naltrexone 12mg in a single multi-dose pen for weight management support. This formulation is designed to activate GLP-1, GIP, and glucagon receptors to help support appetite regulation, reduced cravings, improved insulin sensitivity, and sustained energy levels. Delivered in a convenient 2.4ml multi-dose pen with 240 clicks, it allows for precise weekly dosing for individuals seeking enhanced metabolic efficiency and body composition support.

",Health Tech,Health & Beauty > Health Care,",",true,Title,Default Title,,,,,,,,,0.0,shopify,0,continue,manual,2750.00,,true,false,,,,,,https://cdn.shopify.com/s/files/1/0825/1935/9713/files/Retrexa_Hybrid_multi-dose_peptide_pen.png?v=1779006495,1,Retrexa Hybrid multi-dose pen and packaging on a reflective surface with a starry night sky background,false,,,,adults,,,,,,,,,,,,,,,,,,,,,kg,,1850.00,active retrexa-hybrid-44mg-2-4ml-multi-dose-pen-240-clicks,Noventra Retrexa Hybrid R3t@trutide & Naltrexone Pen 44mg,"

Retrexa Hybrid is an advanced metabolic peptide blend combining R3t@trutide 32mg and Naltrexone 12mg in a single multi-dose pen for weight management support. This formulation is designed to activate GLP-1, GIP, and glucagon receptors to help support appetite regulation, reduced cravings, improved insulin sensitivity, and sustained energy levels. Delivered in a convenient 2.4ml multi-dose pen with 240 clicks, it allows for precise weekly dosing for individuals seeking enhanced metabolic efficiency and body composition support.

Key Features

Contains Retatrutide 32mg + Naltrexone 12mg


Triple-path metabolic support


Activates GLP-1, GIP, and glucagon receptors


Supports appetite suppression and satiety


Helps reduce cravings and emotional eating


Supports improved insulin sensitivity


Assists body-fat reduction while preserving muscle


Promotes steady energy and mood support


Multi-dose pen with 240 clicks


Designed for structured weekly protocols

Dosage & Usage

WEEK 1


  • 4.0mg / 1.5mg

  • Approximately 30 clicks

WEEK 2


  • 6.0mg / 2.25mg

  • Approximately 45 clicks

WEEK 3


  • 6.0mg / 2.25mg

  • Approximately 45 clicks

WEEK 4


  • 8.0mg / 3.0mg

  • Approximately 60 clicks

WEEK 5


  • 8.0mg / 3.0mg

  • Approximately 60 clicks

Administration

Route of Administration


  • Subcutaneous injection

  • Microneedle/dermal application depending on goal

Suggested Injection Areas


  • Abdomen

  • Thigh

  • Upper arm

Suggested Frequency


  • Once weekly

Suggested Dose Range


  • 1.5mg – 3.0mg

  • Approximately 30–60 clicks

Additional Notes


  • Rotate injection sites weekly to avoid irritation

  • Designed for metabolic enhancement and appetite regulation

  • Intended to support sustained satiety and long-term metabolic health
FAQ's & Tips

What is Retrexa Hybrid used for?

Retrexa Hybrid is commonly used to support weight management, appetite suppression, craving control, and metabolic optimization.

How is Retrexa Hybrid administered?

The product is administered through subcutaneous injection using the multi-dose pen system.

What makes Retrexa Hybrid different?

The formula combines Retatrutide and Naltrexone to support both metabolic regulation and craving control in a single protocol.

How often is Retrexa Hybrid used?

The image suggests once-weekly administration.

Can Retrexa Hybrid support fat loss?

The formulation is designed to support fat metabolism, appetite control, and improved insulin sensitivity alongside proper nutrition and activity.

What areas can be injected?

The image indicates administration into the abdomen, thigh, or upper arm.

Research

Retatrutide Research

Retatrutide is a next-generation triple agonist peptide researched for its effects on appetite regulation, energy expenditure, glucose metabolism, and body weight management through GLP-1, GIP, and glucagon receptor activation.

Naltrexone & Craving Regulation

Naltrexone has been studied for its potential role in reducing reward-driven eating behaviors and supporting craving management through opioid receptor modulation.

Metabolic & Fat Loss Support

Research into hybrid metabolic therapies suggests multi-pathway activation may help support improved fat reduction, insulin sensitivity, and metabolic efficiency compared to single-pathway approaches.

Appetite & Behavioral Support

The combination of metabolic and craving-regulation mechanisms is commonly explored for comprehensive weight management and long-term adherence support.

Research into peptide and metabolic therapies is ongoing and individual responses may vary.

Reviews